Alyson Hannigan, Ask2BSure spokesperson, actress, and mom, stars in an Ask2BSure campaign video to raise awareness about ...

GSK has reported positive outcomes from the randomised Phase III GLISTEN trial of the targeted inhibitor of ileal bile acid ...

The GLISTEN trial of GSK's linerixibat has shown that the oral ileal bile acid transporter (IBAT inhibitor was signposted as ...

GSK plc's stock price has significantly outperformed the healthcare sector this year, supported by its healthy Q1 2025 ...

GSK's (GSK) linerixibat achieves significant itch reduction in a late-stage trial for cholestatic pruritus, meeting key goals ...

UK pharma major GSK (LSE: GSK) has unveiled full Phase III data showing its experimental drug linerixibat significantly ...

GSK on Wednesday said it was "well positioned" to absorb potential U.S. pharmaceutical tariffs, citing AI-driven cost cuts ...

GSK has shared the data behind its phase 3 liver disease win, revealing patients on linerixibat reported reductions in ...

The missed PDUFA adds to a string of delays at the FDA in recent weeks, including at least two other missed target action ...

GSK’s share price has fallen significantly in the past 12 months, but this could mean it looks a major bargain now, ...

GSK’s profit rose on better-than-expected performance of HIV, cancer and asthma treatments, offsetting lower vaccine demand ...

GlaxoSmithKline ( ($GSK) ) has shared an update. On May 7, 2025, GSK plc announced the purchase of 687,081 of its own ordinary shares at prices ...